Assenagon Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.63M | Sell |
33,621
-817
| -2% | -$65.9K | ﹤0.01% | 801 |
|
|
2026
Q1 | $2.98M | Sell |
34,438
-854
| -2% | -$81.8K | ﹤0.01% | 703 |
|
|
2025
Q4 | $3.39M | Buy |
35,292
+866
| +3% | +$84.1K | ﹤0.01% | 724 |
|
|
2025
Q3 | $3.28M | Sell |
34,426
-29,384
| -46% | -$2.7M | ﹤0.01% | 707 |
|
|
2025
Q2 | $5.56M | Buy |
63,810
+4,016
| +7% | +$341K | 0.01% | 558 |
|
|
2025
Q1 | $5.37M | Sell |
59,794
-606
| -1% | -$54.2K | 0.01% | 532 |
|
|
2024
Q4 | $4.82M | Buy |
60,400
+1,926
| +3% | +$167K | 0.01% | 692 |
|
|
2024
Q3 | $5.26M | Buy |
58,474
+1,034
| +2% | +$87K | 0.01% | 718 |
|
|
2024
Q2 | $4.52M | Buy |
57,440
+324
| +0.6% | +$26.6K | 0.01% | 661 |
|
|
2024
Q1 | $4.98M | Buy |
57,116
+916
| +2% | +$78.2K | 0.01% | 609 |
|
|
2023
Q4 | $4.63M | Sell |
56,200
-220
| -0.4% | -$16.8K | 0.01% | 660 |
|
|
2023
Q3 | $4.42M | Buy |
56,420
+522
| +0.9% | +$43.7K | 0.01% | 613 |
|
|
2023
Q2 | $4.92M | Sell |
55,898
-250,318
| -82% | -$21.5M | 0.02% | 499 |
|
|
2023
Q1 | $24.7M | Buy |
306,216
+250,547
| +450% | +$20.4M | 0.09% | 195 |
|
|
2022
Q4 | $4.33M | Sell |
55,669
-681,234
| -92% | -$55.2M | 0.02% | 565 |
|
|
2022
Q3 | $59.5M | Buy |
736,903
+708,711
| +2,514% | +$63.7M | 0.23% | 94 |
|
|
2022
Q2 | $2.53M | Buy |
28,192
+17,649
| +167% | +$1.79M | 0.01% | 745 |
|
|
2022
Q1 | $1.17M | Hold |
10,543
| – | – | ﹤0.01% | 1017 |
|
|
2021
Q4 | $1.09M | Sell |
10,543
-1,975
| -16% | -$229K | ﹤0.01% | 1004 |
|
|
2021
Q3 | $1.57M | Buy |
12,518
+11,416
| +1,036% | +$1.48M | 0.01% | 772 |
|
|
2021
Q2 | $137K | Sell |
1,102
-198,710
| -99% | -$24.9M | ﹤0.01% | 1163 |
|
|
2021
Q1 | $23.6M | Buy |
+199,812
| New | +$23.4M | 0.1% | 184 |
|
|
2020
Q4 | – | Sell |
-67,419
| Closed | -$7.01M | – | 1160 |
|
|
2020
Q3 | $7.01M | Buy |
67,419
+50,852
| +307% | +$5.11M | 0.04% | 264 |
|
|
2020
Q2 | $1.52M | Buy |
16,567
+8,792
| +113% | +$843K | 0.01% | 677 |
|
|
2020
Q1 | $701K | Sell |
7,775
-33,108
| -81% | -$3.52M | 0.01% | 597 |
|
|
2019
Q4 | $4.64M | Sell |
40,883
-108,713
| -73% | -$11.9M | 0.03% | 251 |
|
|
2019
Q3 | $16.2M | Buy |
149,596
+120,203
| +409% | +$12.5M | 0.11% | 127 |
|
|
2019
Q2 | $2.86M | Sell |
29,393
-11,412
| -28% | -$1.04M | 0.02% | 422 |
|
|
2019
Q1 | $3.72M | Sell |
40,805
-278,758
| -87% | -$24.9M | 0.03% | 366 |
|
|
2018
Q4 | $29.1M | Buy |
319,563
+291,517
| +1,039% | +$27.2M | 0.33% | 72 |
|
|
2018
Q3 | $2.76M | Buy |
+28,046
| New | +$2.59M | 0.03% | 443 |
|
|
2018
Q2 | – | Sell |
-473,521
| Closed | -$38M | – | 542 |
|
|
2018
Q1 | $38M | Buy |
+473,521
| New | +$39.1M | 0.49% | 53 |
|
Other funds holding MDT
Assenagon Asset Management's MDT Position: Q2 2026 in Review
Assenagon Asset Management reduced its Medtronic (MDT) stake by 2.4% in Q2 2026, selling an estimated $65.9K and leaving 33,621 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #801.
Assenagon Asset Management first reported a position in MDT in Q1 2018 and has held it in 32 quarters since. The position peaked at $59.5M in Q3 2022. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Assenagon Asset Management held 33,621 shares of Medtronic worth $2.63M as of Q2 2026.
- Assenagon Asset Management sold 817 Medtronic shares in Q2 2026, an estimated $65.9K.
- Medtronic made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #801 holding.
- Assenagon Asset Management first reported a position in Medtronic in Q1 2018 and has held it in 32 quarters since.
- Assenagon Asset Management's Medtronic position peaked at $59.5M in Q3 2022.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.